This study evaluated the level of fear and anxiety related to the COVID-19 outbreak, in infertile women whose ART cycles were delayed due to the pandemic. An online survey was sent to women whose A...
10 December 2020 in International Journal Of Clinical Practice
Objective To investigate the effect of COVID‐19 on sexual dysfunction in women. Material and methods The women diagnosed with COVID‐19 and hospitalized at a tertiary hospital were included. They completed the Introductory Data Form, the Female Sexual Function Index‐(FSFI), and the Short Form‐36 Quality of Life Scale (SF‐36). Results 15 women between the ages of 19‐49 who completed the treatment protocol, discharged at least 14 days before, and who had not been diagnosed as sexual dysfunction sexually active earlier were included to the study. It was detected that weekly sexual intercourse before and after COVID‐19 significantly differed (p=0.047). The frequency of relationships decreased statistically after COVID‐19. The mean value of the FSFI satisfaction score differs from COVID‐19 before and after diagnosis (p=0.012). The mean satisfaction score before COVID‐19 was 3.47, and after COVID‐19 was 2.93. The score of the subgroups of FSFI did not differ from COVID‐19 before and after diagnosis (p>0.050). The median value of SF‐36 pain differs from COVID‐19 before and after diagnosis (p=0.008). Conclusion It was concluded that the frequency of sexual intercourse, sexual satisfaction in women decreased after COVID‐19 disease, and the quality of life scores did not change in a statistically significant way.
30 October 2021 in Archives of Gynecology and Obstetrics
Objective(s): The aim of the present study is to investigate probable acute effects of vitamin D on ischemia-reperfusion injury in the rat ovary. Materials and Methods: A group of 30 Wistar albino rats was divided into five groups of 6 each. Group 1: underwent laparotomy only and the ovaries were removed. Group 2: 3-hr ischemia followed by excision of the ovaries. Group 3: 3-hr ischemia and 3-hr reperfusion and the ovaries were removed. Group 4: vitamin D was administered 30 min prior to the 3-hr of ischemia and the ovaries were excised at the end of ischemia period. Group 5: vitamin D was administered 30 min prior to the 3-hr of ischemia and 3-hr reperfusion then the ovaries were removed at the end of reperfusion. The ovaries excised in each group also underwent biochemical and histopathologic analysis. MDA (malondialdehyde), SOD (superoxide dismutase), NO (nitric oxide), TAS (total antioxidant score), TOS (total oxidant score) were analyzed as biochemical parameters. Results: There were no significant differences between groups in TAS, TOS, or OSI (P>0.05). MDA levels were lower in the vitamin D treatment groups especially in group 5, significantly (P<0.05). In the histopathologic evaluation, we established that an improvement with vitamin D treatment. According to tissue injury scores, vascular congestion score was significantly different between group 3 and 5 (P<0.05). Conclusion: Vitamin D seems an effective molecule for protection of ischemia-reperfusion injury in rat ovary. There is some significant improvement in oxidative damages with vitamin D treatment.